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Rob Lavigne3,4 and Robert Atterbury1* on behalf of the AntibioPhage Consortium
1 School of Veterinary Medicine and Science, University of Nottingham Sutton Bonington Campus, Sutton Bonington,
United Kingdom, 2 Infectiologie et Santé Publique, Institut National de la Recherche Agronomique, Université François
Rabelais de Tours, Nouzilly, France, 3 Department of Veterinary and Animal Sciences, Faculty of Health and Medical
Sciences, University of Copenhagen, Copenhagen, Denmark, 4 Laboratory of Gene Technology, Department of Biosystems,
KU Leuven, Leuven, Belgium
We have performed microbiological and genomic characterization of an historic
collection of nine bacteriophages, specifically infecting a K1 E. coli O18:K1:H7 ColV+
strain. These phages were isolated from sewage and tested for their efficacy in vivo
for the treatment of systemic E. coli infection in a mouse infection model by Smith
and Huggins (1982). The aim of the study was to identify common microbiological and
genomic characteristics, which co-relate to the performance of these phages in in vivo
study. These features will allow an informed selection of phages for use as therapeutic
agents. Transmission electron microscopy showed that six of the nine phages were
Podoviridae and the remaining three were Siphoviridae. The four best performing
phages in vivo belonged to the Podoviridae family. In vitro, these phages exhibited very
short latent and rise periods in our study. In agreement with their microbiological profiles,
characterization by genome sequencing showed that all six podoviruses belong to the
Autographivirinae subfamily. Of these, four were isolates of the same species (99%
identity), whereas two had divergent genomes compared to other podoviruses. The
Siphoviridae phages, which were moderate to poor performers in vivo, exhibited longer
latent and rise periods in vitro. Two of the three siphoviruses were closely related to
each other (99% identity), but all can be associated with the Guernseyvirinae subfamily.
Genome sequence comparison of both types of phages showed that a gene encoding
for DNA-dependent RNA polymerase was only present in phages with faster replication
cycle, which may account for their better performance in vivo. These data define a
combination of microbiological, genomic and in vivo characteristics which allow a more
rational evaluation of the original in vivo data and pave the way for the selection of
phages for future phage therapy trails.
Keywords: Escherichia coli, bacteriophage, therapeutics, one-step growth curve, transmission electron
microscopy, phylogeny, DNA-dependent RNA polymerase
INTRODUCTION
The rapid increase in antimicrobial resistance, is a major cause of concern for both the
animal and human health, and threatens to render many clinically important antibiotics
ineffective (Drulis-Kawa et al., 2012). There is now an urgent need for new antimicrobials and
alternative approaches to infection control. Bacteriophages (phages) are one such approach with
evidence of antibacterial properties, recently highlighted in 2016 by a joint United Kingdom
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Department of Health and Wellcome Trust-funded expert panel
review of alternatives to antibiotics, and reviewed earlier (Drulis-
Kawa et al., 2012; Nobrega et al., 2015).
Phages were discovered in the early twentieth century by
Twort (1915) and d’Hérelle (1917). Soon after their discovery
d’Herelle and others performed several trials using phages to treat
bacterial infections in humans and animals. Although some of
these trials were successful, they suffered from a lack of proper
controls and the use of phage whose activity and reliability were
unknown. This, together with the poor understanding at the
time of the mechanism of bacterial pathogenesis, the nature
of the interaction between bacteria and phages and the start
of the antibiotic era, discredited the idea of using phages as
antimicrobials in the West. The clinical use of phage continued
in Eastern Europe, although studies published often lacked
appropriate control groups and sometimes used phage alongside
other antimicrobials, making it difficult to evaluate how much
phage contributed to the efficacy of the treatment (Barrow and
Soothill, 1997; Summers, 1999, 2001).
Phage therapy continues in Russia and Eastern Europe to
this day (Expert Round Table on Acceptance and Therapy Re-
implementation of Bacteriophage, 2016). In the West, phage
therapy was revived in the 1980s by Smith and Huggins in a series
of carefully controlled experiments using systemic Escherichia
coli and Enterotoxigenic E. coli (ETEC) infections in mice,
calves, pigs, and sheep (Smith and Huggins, 1980, 1982, 1983;
Smith et al., 1987a,b). These studies highlighted that appropriate
selection of phages and their application in infections where
phage activity is likely to be optimal, can lead to a successful
outcome.
Smith and Huggins’s (1982) study reported the isolation of
phages which attached specifically to the K1 capsular antigen of
E. coli. The capsular polysaccharides (K antigens) are linked to
virulence in E. coli (Jann and Jann, 1987), and strains possessing
the K1 antigen exhibit increased invasiveness and are associated
with septicaemia and meningitis (Smith and Huggins, 1982;
Silver and Vimr, 1990). The K1-specific phages were used to treat
and prevent E. coli septicaemia or meningitis in mice (Smith and
Huggins, 1982). Some phage-resistant mutants were recovered
following the experiments but these were largely K1 negative,
and thus avirulent. There were differences in therapeutic efficacy
between the nine phages tested. Of the nine, one, phage R,
was more effective than any of the antibiotic treatments used,
which included several doses of streptomycin. In the present
study, we have performed detailed microbiological and genomic
characterization of the nine phages originally isolated by Smith
and Huggins. Our findings define common phenotypic and
genomic characteristics which can be related to the differences in
the in vivo performance of these phage. These features could be
useful in the selection of phage from closely related phage groups
which are most likely to be effective biological control agents.
MATERIALS AND METHODS
Bacterial Isolate and Phage Collection
The host bacterium E. coli O18:K1:H7 ColV+, referred to as
MW, and the collection of nine phages used in this study are
those isolated by Smith and Huggins (1982). Briefly, MW is
a prototrophic, non-haemolytic human clinical E. coli isolated
from the brain of a baby suffering from meningitis and
which produces experimental septicaemia in mice, chickens and
colostrum-deprived calves (Smith and Huggins, 1980, 1982). The
nine phages were isolated from samples of crude sewage and
from pig markets by Smith and Huggins (1982). In compliance
with the new taxonomic classification for phages (Lavigne et al.,
2008), the original names of phages have been modified and listed
under ‘Phage name’ (Table 1) with the ‘Phage ID’ referring to the
original name of phages (Smith and Huggins, 1982).
Growth Rate of MW E. coli
The mid-exponential phase of MW E. coli was determined
by growing the bacteria in LB broth. For this, LB broth was
inoculated with an overnight culture of MW E. coli to an OD600nm
of 0.01. The first sample was taken at the point of inoculation and
the culture was incubated shaking at 100 rpm at 37◦C. Samples
were taken out at hourly intervals for 7 h and finally after 24 h to
enumerate the bacteria (Miles et al., 1938). For this, each sample
was serially diluted in Phosphate Buffered Saline (PBS, Sigma–
Aldrich) and 0.1 mL of each dilution was spread onto LBA plates
which were then incubated overnight at 37◦C. After incubation,
the bacterial colonies were counted and CFU/mL calculated.
Propagation of Phages in MW E. coli
All phage were propagated using MW as the host E. coli strain.
Phage lysates were produced either in Luria-Bertani (LB) broth
or on LB agar (LBA) plates (Sigma–Aldrich). Broth lysates
were prepared by inoculating LB with an overnight culture
of MW to achieve an optical density of 0.01 (OD600nm). The
culture was incubated at 37◦C, shaking (100 rpm) for 2 h until
the cells reached mid-exponential growth phase (108 CFU/mL)
before infecting with a phage suspension at a multiplicity of
infection (MOI) of 0.1. The culture was further incubated with
gentle agitation (100 rpm) overnight at 37◦C. Phage lysates
were centrifuged at 5,000 × g for 10 min to pellet the cellular
debris. The supernatant containing the phage was filtered using a
0.22µm filter (Millipore). The phage were enumerated by serially
diluting the lysate in SM buffer (50 mM Tris-Cl (pH 7.5), 0.1M
NaCl, 8 mM MgSO4·7H2O and 0.01% gelatin). A 0.1 mL volume
of each dilution was added separately to 3 mL of molten LBA
containing 0.5% agar and 0.1 mL of an overnight culture of MW.
This was poured onto LBA plates containing 1% agar which were
then incubated overnight at 37◦C. All phage lysates were stored
at 4◦C until required.
Polyethylene Glycol (PEG) Precipitation
A high titre phage suspension (1010–1011 PFU/mL) was produced
by PEG precipitation according to the method of Yamamoto
et al. (1970). Briefly, overnight phage lysates were produced
in 2L Erlenmeyer flasks. The flasks were removed from the
incubator and supplemented with 1 µg/mL each of DNase and
RNase (Sigma–Aldrich) before incubating at room temperature
for 30 min. To allow the phage particles to dissociate from
cellular debris, NaCl was added to a final concentration of 1M
and the lysates were incubated on ice for 1 h. The cellular
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debris was removed by centrifugation at 11,000 × g (Beckman
Coulter Avanti J-E series centrifuge) for 10 min at 4◦C. The phage
particles were precipitated by incubating the lysates overnight at
4◦C with PEG 8000 (Sigma–Aldrich) to a final concentration of
10% w/v. The precipitated phage were pelleted by centrifugation
at 35,000 × g for 15 min at 4◦C. The phage pellet was re-
suspended by soaking in SM buffer for 1 h at room temperature.
Phage were extracted from PEG and cell debris by adding an
equal volume of chloroform to the lysates which were mixed
by gentle inversion for 30 s and the aqueous phase containing
phage particles (upper layer) was separated by centrifugation
at 13,000 × g (Thermo Electron Corporation Heraeus Pico 17
centrifuge) for 20 min.
Phage Purification by Ultracentrifugation
High titre phage preparations were further purified using a
caesium chloride (CsCl) gradient as described by Sambrook and
Russell (2001) and adapted by Hooton et al. (2011). Briefly,
CsCl was mixed with the phage lysate to a final concentration
of 0.75 g/ml. The mixture was centrifuged at 240,000 × g for
24 h (15◦C) (Beckman TL 100 series centrifuge). The phage band
was extracted by piercing through the ultracentrifuge tube with
a sterile 21-gauge hypodermic needle (Medisave). To remove
the residual CsCl, the sample was filtered using an Amicon R©
Ultra −0.5 mL 30 K membrane filter (Millipore) as per the
manufacturer instructions.
Transmission Electron Microscopy (TEM)
The sample (3 µL) was applied to a hydrophilic (freshly glow-
discharged) carbon-coated Pioloform film coated 300 square
mesh copper EM grid (Agar Scientific Ltd.) and left for 2 min
to adsorb. Excess sample was removed with a small piece of
Whatman No. 1 filter paper, leaving a thin film of sample on the
grid surface. The grid was rinsed twice immediately by adding
5 µl distilled de-ionized water and removing excess as described
above. One drop of uranyl acetate (1% and 0.22 µm filtered) was
applied to the grid and the excess removed immediately. The grid
was then allowed to dry. Once dry, the grids were observed on
a JEOL JEM-1400 TEM with an accelerating voltage of 100 kV.
Digital images were recorded using a SIS Megaview III digital
camera with iTEM software.
Phage Adsorption
For each anti-K1 phage, a MW E. coli culture at mid-exponential
phase was infected at an MOI of 0.1. The adsorption rate for
each phage was determined by taking samples every 2 min for
up to 12 min. Bacterial cells with adsorbed phage were removed
by centrifugation at 13,000 × g. The supernatant was then
filtered using 0.45 µm filter (Millipore) and unbound phage were
enumerated on LBA overlay containing 0.1 mL of MW E. coli on
LBA plates, incubated overnight at 37◦C. The adsorption period
was considered as the time taken to achieve a 90% reduction in
free, unbound phage (i.e., 1 log10 PFU/mL reduction from the
initial titre) (Weber-Da˛browska et al., 2016).
One-Step Growth Curve
A mid-exponential phase MW culture was infected with the
respective phage at an MOI of 0.1. The phage particles were
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allowed to adsorb to the time of 90% adsorption as calculated
in the in vitro adsorption assay. The lysate was then diluted to
104 PFU/ml in LB broth (Hyman and Abedon, 2009). Samples
of the infected culture were collected every 2 min for 20 min
for the Podoviridae or every 5 min for up to 60 min for the
Siphoviridae, and unbound phages were enumerated on LBA
overlays as described above. The burst size was calculated as the
difference in the plaque forming unit (PFU) between the end of
rise period and the latent period (Bolger-Munro et al., 2013).
Genomic DNA Extraction and
Sequencing
DNA extraction of the ultracentrifuged phage preparation was
performed using the Wizard R© DNA clean-up system (Promega).
Briefly, the phage sample was mixed thoroughly with the DNA
Clean-up resin to break open the capsids and release DNA.
The DNA and resin mix was filtered through a mini-column
using a syringe barrel. The mini-column was washed with 80%
isopropanol and the purified DNA was eluted with pre-warmed
deionized water.
Genome sequencing of the phage was completed at NU-Omics
facility, University of Northumbria. A DNA sequencing library
of the phage genomic DNA (50 ng) was created using Illumina
Nextera XT DNA preparation kit and libraries were sequenced
using Illumina V2 2 bp× 250 bp chemistry on the Illumina MiSeq
Platform.
Phage Genome Sequence Analysis
Raw sequence reads in FastQ files were quality-filtered using
Cutadapt (Martin, 2011) and Sickle (Joshi and Fass, 2011). Due
to massive over sequencing a subset of reads was taken for each
phage, to enable manageable assemblies with read depths of
approximately 200× (quality filtered FastQ data was randomly
subsampled using a Python script1). The sequence reads were de
novo assembled using SPAdes (v3.6.2) (Bankevich et al., 2012)
and in each case the phage genomes were resolved as a single
contig. To circularize the phage genome, the beginning and
the end of each assembled genome was joined with a short
string of ‘Ns.’ The raw sequence reads from the quality filtered
FastQ files were re-mapped to the above genome sequence,
using Stampy (Lunter and Goodson, 2011) and visualized using
Samtools and BCFtools (Li et al., 2009). Any missing nucleotide
bases replaced the N’s, confirming the circularity of the phage
genome. The intactness of each phage genome was also confirmed
using PHAST (Zhou et al., 2011). Phage genomes were annotated
using Prokka (Seemann, 2014), which uses Prodigal to predict
coding sequences (CDSs) and also defines the ribosomal and
transfer RNA genes (rRNA and tRNA), non-coding RNA and
leader signal peptides. The nucleotide sequence of CDSs was
used to perform blast searches against the Conserved Domain
Database (CDD) (v3.15) of NCBI (Marchler-Bauer et al., 2015).
The predicted functionality of the phage genomes was further
improved by comparing the functional annotation generated by
Prokka, CDD and the best matching published genome in NCBI.
Nucleotide and protein comparisons were performed using the
1https://github.com/fjruizruano/ngs-protocols/blob/master/fastq-pe-random.py
command line BLAST+ algorithm (Camacho et al., 2009). The
nucleotide and amino acid sequence alignments were produced
by ClustalW (CLUSTAL 2.1) (Thompson et al., 1994). The
maximum likelihood phylogenetic analysis was performed using
the generalized time-reversible (GTR) model to infer nucleotide
evolution and Jones-Taylor-Thornton 1992 (JTT +CAT) model
for protein evolution, with FastTree (Price et al., 2009). The
nucleotide BLAST comparison figures were generated using
Easyfig (Sullivan et al., 2011). The color coding for functional
annotation was added using Inscape 0.922. The sequence read
data of phage genomes has been submitted to the European
Nucleotide Archive (ENA) and the annotated phage genome
sequences have been deposited in the NCBI GenBank database
(Supplementary Table S1).
RESULTS
Phage Morphology
Transmission electron microscopy showed that six of nine
phage studies used by Smith and Huggins (1982) belonged
to the Podoviridae family (Table 1), which are known to
have short, non-contractile tails (Ackermann, 2000). Phage
vB_EcoP_R (R), the best performing phage reported by Smith
and Huggins (Figure 1A), was also a podovirus with an
icosahedral head (average diameter 46 ± 5 nm) and a very
short tail (mean diameter 10 ± 5 nm). The remaining three
phages belonged to the Siphoviridae family (Table 1). Phages
from this family have a long flexible non-contractile tail with
tail fibers (Fokine and Rossmann, 2014). For example, phage
vB_EcoS_P (P) (Figure 1B), the poor performing phage in the
in vivo study (Smith and Huggins, 1982) was a Siphoviridae phage
of 150 ± 5 nm in size, with icosahedral head (average diameter
49± 5 nm) and long tail (average diameter 101± 5 nm).
Growth Characteristics
Interestingly, high titre phage lysates (109–1010 PFU/ml) for the
Siphoviridae phages could only be produced using the plate lysate
approach, whereas high titre lysates were easily achieved for the
six Podoviridae phages from liquid lysates in LB broth. The time
2https://inkscape.org/en/
FIGURE 1 | Negative staining transmission electron microscopic images of
phages after ultracentrifugation. (A) Podoviridae phage R. (B) Siphoviridae
phage P.
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taken for the phages to adsorb to MW E. coli varied between
4 and 8 min. The best performing phages from the Smith and
Huggins’s in vivo study, Podoviridae phages R, vB_EcoP_D (D),
vB_EcoP_B (B) and vB_EcoP_C (C), exhibited the shortest latent
period (<2 min), a rapid rise period (2–6 min) with a small
burst size (19–48 PFU per infected cell). The growth cycle for
these four podoviruses was between 10 and 16 min (Table 1).
The Podoviridae phages vB_EcoP_F (F) and vB_EcoP_K (K) were
moderate performers in the in vivo study (Smith and Huggins,
1982 and Table 1). Although, phage F had a latent period of
<2 min like the best performing phages in vivo (R, D, B and C),
it showed a large burst size (213 PFU per infected cell). Finally,
phage K had the longest latent period of 8 min followed by a
rise period of 8 min and the longest growth cycle of 20 min,
compared to the other podoviruses. The three Siphoviridae
phages [vB_EcoS_G (G), vB_EcoS_L (L), P] were moderate to
poor performers in the in vivo experiment. These phages showed
a longer latent (10–35 min) and rise period (10–24 min) and
there was wider variation in the burst sizes between these phages,
ranging between 3 and 315 PFU per infected cell. The duration
of growth cycle in the three Siphoviridae phages was longer
(28–53 min), compared with the Podoviridae phages (Table 1).
Genome Sequence Analysis
Illumina MiSeq sequencing generated approximately 150–650
million basepairs (bp) per phage genome. A subsample of this
data was used to assemble each phage genome at a read depth
of approximately 200× (Supplementary Table S1).
Genome sequence analysis showed that the six Podoviridae
phages had genome sizes that ranged between 38025 and 45259
bps, with a G+C content ranging between 45 and 49% and
contained 46–61 CDSs. The remaining three Siphoviridae phages
had genomes of 41039–41624 bps in size, with a higher G+C
content of 51% and their genomes were composed of 62–68 CDSs
(Table 1).
To predict the type of termini of nine phages, the amino
acid sequence of the large terminase protein from these phages
was compared with the terminase protein from published
phages with well-studied DNA packaging mechanisms (Casjens
and Gilcrease, 2009). The amino acid sequence of the large
terminase subunit from Escherichia virus K1E, K1F, K1G and
K1H, was also includes as the best matching published sequence
to the Podoviridae and Siphoviridae phages in this study. The
phylogenetic analysis showed that the six Podoviridae phages
R, B, C, D, K and F were placed in the clade with the phages
with short direct terminal repeats (Figure 2). The phages R,
B, C, D and K were closely related to the Escherichia virus
K1E and the phage F grouped with the Escherichia virus K1F.
The Siphoviridae phages along with the Escherichia virus K1G
and K1H formed a clade, and were closely related with the
phages with different headful packaging strategies (Figure 2).
Further comparison of the Podoviridae phages R, B, C, D and
K with the Escherichia virus K1E showed that these phages
have short direct terminal repeats of 250–289 bp in length
with 92–96% sequence identity with the short direct terminal
repeats in the Escherichia virus K1E. In the phage F, each
short direct terminal repeat was 165 bp in length and showed
88% identity to the short direct terminal repeats in Escherichia
virus K1F.
The phylogenetic analysis comparing the Podoviridae phages
with selected representative phage species from all genera of the
subfamily Autographivirinae showed that the best performing
phages in vivo, R, D, C and B grouped together and were
closely related to Aeromonas phage phiAS7, an unassigned phage
in the subfamily Autographivirinae (Figure 3). Phage K was
more closely related to the phage species in the genus Sp6virus
of the subfamily Autographivirinae. The Escherichia virus K1E
was also included in the genus Sp6virus. Finally, phage F was
included in a clade with two unclassified phages of subfamily
Autographivirinae of which the best matched phage genome was
of Escherichia phage PE3-1, a member of phage representing the
T7virus genus (Figure 3).
The BLASTn comparison of the Podoviridae phage genomes
using phage R as the reference showed an average of 99%
identity with phages B, C and D (Figure 4). The moderately
performing Podoviridae phages, K and F had divergent genomic
content compared to the best performing Podoviridae phages
R, D, C and B. Fourteen genes present in the best performing
phage R were divergent from the genome of phage K. These
included 10 genes with predicted hypothetical function and
the remaining four genes encoding for DNA-dependent RNA
polymerase, bacteriophage 1.1 protein, DNA mimic Ocr and a
homing endonuclease. Finally, the genomic content of phage F
differed most among the other six Podoviridae phages (Figure 4
and Supplementary Table S2). Phylogeny and the nucleotide
sequence comparison of the gene encoding DNA-dependent
RNA polymerase from the Podoviridae phages R, B, C, D and
F showed that the phages R, B, C and D were highly identical
to each other (99–100%). Phage F only shared 47% nucleotide
sequence identity with the phages, R, B, C and D based on
the nucleotide sequence of DNA-dependent RNA polymerase
(Supplementary Figures S1, S2).
The phylogenetic analysis comparing the three Siphoviridae
phages (P, G and L) with the published genomes from all
genera of the subfamily Guernseyvirinae grouped the three
phages in one clade, closely related to the two Salmonella
phages (Salmonella phage wksl3 and Salmonella phage SS3e)
in genus Jerseyvirus (Figure 5). Comparative analysis of the
genome of the poor performing Siphoviridae phage P with that
of the phages G and L showed that phage P contained nine
genes which were divergent from phages G and L. Five of the
nine genes had functions related to putative Mte8-like protein,
phage tail assembly chaperone, superinfection immunity protein,
putative helicase-primase, HNH endonuclease and the remaining
four were predicted hypothetical function genes (Figure 6 and
Supplementary Table S3).
The gene encoding an endosialidase was present in all
nine phages (Figures 4, 6). The phylogenetic analysis and
comparison of nine phages based on the nucleotide sequence
of the endosialidase gene showed that the Podoviridae phages
R, B, C, D, K and F were closely related to each other with
percentage sequence identity ranging between 92 and 100%.
The Siphoviridae phages P, G and L shared >95% endosialidase
nucleotide sequence identity with each other and were only
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FIGURE 2 | The maximum likelihood phylogenetic comparison of the amino acid sequence of the large terminase subunit of nine phages (Smith and Huggins, 1982)
with the large terminase subunit from selected published tailed phages with well characterized DNA packaging strategy.
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FIGURE 3 | The maximum likelihood phylogenetic comparison of the Podoviridae phages (Smith and Huggins, 1982) to the selected published genomes of phage
species from all genera of subfamily Autographivirinae.
distantly related to six Podoviridae phages with the nucleotide
sequence identity of 52% (Supplementary Figures S3, S4).
DISCUSSION
Smith and Huggins (1982) tested the performance of nine
K1 specific E. coli phages for the treatment of septicaemia,
using mice model of infection. In these pioneering phage
therapy experiments, the mice were infected by intramuscular or
intracerebral route with MW E. coli. The K1 specific phages were
administered intramuscularly to treat the infection. Interestingly,
not all phages tested were equally effective and showed a gradient
of treatment efficiency, noted after 8 h interval between infection
and treatment (Smith and Huggins, 1982 and Table 1). From the
best performing phages, phage R was investigated further and
was more effective in treatment than multiple doses of either
tetracycline, trimethoprim, ampicillin or chloramphenicol. It was
also reported that phage R and the other of the more effective
phages cleared broth cultures of the K1 positive strain more
quickly than those which were less effective (Smith and Huggins,
1982).
In the present study, we report the microbiological and
genomic characteristics of these nine K1 specific E. coli phages
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FIGURE 4 | A BLASTn comparison of the Escherichia virus K1E and six Podoviridae phages, constructed with EasyFig.
and relate these characteristics to their performance in the
in vivo study. It was interesting to observe that even though
all nine phages were K1-specific, morphologically they belonged
to two different phage families (Podoviridae and Siphoviridae)
(Figure 1). There were also differences between the podoviruses
and siphoviruses based on their growth profiles. The best
performing phages in Smith and Huggins’s in vivo study
belonged to the Podoviridae family, with a faster replication cycle
characterized by shorter latent and rise periods. In contrast, the
Siphoviridae phages which were moderate to poor performers,
exhibited longer latent and rise periods (Table 1). These
differences were observed in the bacterial growth media (LB)
unlike the report by Bull et al. (2002) in which the differences
in the replication of K1-specific and non-K1 phage could only be
observed in mouse sera. This suggests that phenotypic differences
between these phages can be observed without the need for
any specialist growth media. In a study of T7-like phages, a
phage KPO1K2, capable of infecting Klebsiella pneumoniae isolate
B5055, was a Podoviridae phage and was proposed as a potential
therapeutic agent against this pathogen. High titres of phage
KPO1K2 were observed in the kidney and urinary bladder 6 h
after intraperitoneal injection in infected mice. The growth
profile of PhiKPO1K2 showed a latent period of 15 min and a
burst size of 140 (Verma et al., 2009). Another study describing
the characterization of lytic phages for the treatment of multidrug
resistant Klebsiella pneumoniae showed that both Podoviridae
and Siphoviridae phages had a similar latent period of 15 min
and a burst size of∼50–60 (Ke˛sik-Szeloch et al., 2013). Although
these studies suggest a longer latent period for being the best
phage, our study suggests that the Autographivirinae phages that
replicate faster in liquid culture, performed better in the mouse
infection model. In contrast, the Guernseyvirinae phages that
replicated more slowly due to longer time (latent period) required
to assemble into complete phage particles performed poorly
in vivo. This is also highlighted by the fact that it was difficult
to produce high titre preparations of the Siphoviridae phages in
the liquid LB media, requiring culture on LBA plates. It remains
to be seen whether this is a general phenomenon for other phages
or it is just restricted to the phages of these taxonomic groups.
A characteristic of K1 phage genomes is the presence of
a gene encoding for endosialidase which accounts for the
phage specificity to the K1 capsular antigen of the K1 E. coli
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FIGURE 5 | The maximum likelihood phylogenetic comparison of the
Siphoviridae phages (Smith and Huggins, 1982) to the published genomes of
phage species from all genera of subfamily Guernseyvirinae.
strains (Tomlinson and Taylor, 1985; Mushtaq et al., 2005). The
predicted gene encoding an endosialidase was present in all
nine K1 phages confirming the specificity of these phages to the
K1 E. coli strain. The phylogenetic placement of the four best
performing phages (R, D, B and C) and the moderate performing
phage F as closely related to the unassigned and unclassified
members of the subfamily Autographivirinae suggests that these
phages have divergent genomes compared to the phages in other
genera within this subfamily. However, phage K which was a
moderate performing phage of all Podoviridae phages had a more
resolved position in the phylogeny as being closely related to the
phages from genus Sp6virus which includes the Escherichia virus
K1E. The three Siphoviridae phages were more closely related to
the Salmonella phages in the genus Jerseyvirus which reflects that
these phages may also infect Salmonella strains.
The best performance of Podoviridae phages R, D, B, and C
in vivo could be associated with a combination of their rapid
replication cycle and the presence of the gene encoding for DNA-
dependent RNA polymerase in the genome of these phages.
Although the phage K was phylogenetically closely related to the
Escherichia virus K1E, many genes in the genome of this phage
were divergent from the Escherichia virus K1E, including the gene
encoding for DNA-dependent RNA polymerase suggesting that
phage K had diverged from the phages in the genus Sp6virus.
In phage T7, the phage-dependent RNA polymerase and the
bacteriophage 1.1 protein are the early gene products which
play a role in regulating host transcription and protein synthesis
(McAllister and Barrett, 1977). The phage T7 RNA polymerase
is also directly involved in phage DNA replication (Hinkle,
1980). If the gene encoding phage-dependent RNA polymerase
is functional, it enables a rapid shut-off of host transcription by
5 min after infection, thus allowing a much faster replication
cycle of the phages. In the absence of this gene, shut-off of
host transcription is delayed and is instead activated by the
bacteriophage 1.1 protein after 15 min of infection. In the absence
of all early gene products, the host shut-off is observed at least
30 min after the infection (McAllister and Barrett, 1977). The
moderate and poor performing phages in this study lacked these
genes. The absence of these genes may be responsible for the
longer latent period observed and thus the poor performance
of these phages in vivo, as more time would be required to
FIGURE 6 | A BLASTn comparison of three Siphoviridae phages, constructed with EasyFig.
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shut-off the host transcription. The moderate performance of
phage F in vivomay also be linked to its different genomic content
compared to the four best performing phages (R, D, B and C) and
a large burst size. Similarly, the presence of the gene encoding
the superinfection immunity protein in the Siphoviridae phage
P, which is a characteristic of prophages (Brüssow and Kutter,
2005) may also explain its poor performance in vivo. Selecting
phage based on the phenotypic and genomic characteristics may
not guarantee success in vivo (Tsonos et al., 2014) but if common
phenotypic and genomic features can be identified then these can
certainly be used to make targeted phage selection and could also
help in reducing the number of animals used in experiments.
In the K1-specific phages, the presence of the gene encoding for
DNA-dependent RNA polymerase only in the genomes of phages
with very fast replication cycle and their best performance in vivo
suggests the combination of these phenotypic and genomic
characteristics might be used as a marker for selection of suitable
phages for phage therapy trails in the future.
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